Minapharm Pharmaceuticals (CAI:MIPH) EV-to-EBITDA : (As of Jun. 19, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Minapharm Pharmaceuticals EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Minapharm Pharmaceuticals's enterprise value is E£4,221 Mil. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its EBITDA for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's EV-to-EBITDA at this moment.

The historical rank and industry rank for Minapharm Pharmaceuticals's EV-to-EBITDA or its related term are showing as below:

CAI:MIPH' s EV-to-EBITDA Range Over the Past 10 Years
Min: 0 Med: 0 Max: 9.35
Current: 8.8

During the past 2 years, the highest EV-to-EBITDA of Minapharm Pharmaceuticals was 9.35. The lowest was 0.00. And the median was 0.00.

CAI:MIPH's EV-to-EBITDA is ranked better than
70.14% of 710 companies
in the Drug Manufacturers industry
Industry Median: 14.355 vs CAI:MIPH: 8.80

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-19), Minapharm Pharmaceuticals's stock price is E£191.98. Minapharm Pharmaceuticals does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2022. Therefore, GuruFocus does not calculate Minapharm Pharmaceuticals's PE Ratio at this moment.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Minapharm Pharmaceuticals EV-to-EBITDA Historical Data

The historical data trend for Minapharm Pharmaceuticals's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Minapharm Pharmaceuticals EV-to-EBITDA Chart

Minapharm Pharmaceuticals Annual Data

Trend

Dec22

Dec23

EV-to-EBITDA

2.44

9.65

Minapharm Pharmaceuticals Quarterly Data
	Dec22	Dec23
EV-to-EBITDA	-	-

Competitive Comparison of Minapharm Pharmaceuticals's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Minapharm Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Minapharm Pharmaceuticals's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Minapharm Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Minapharm Pharmaceuticals's EV-to-EBITDA falls into.

Minapharm Pharmaceuticals EV-to-EBITDA Calculation

Minapharm Pharmaceuticals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	4220.879	/
	=

Minapharm Pharmaceuticals (CAI:MIPH) EV-to-EBITDA Explanation

Minapharm Pharmaceuticals's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	191.98	/
	=

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Minapharm Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Minapharm Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Minapharm Pharmaceuticals (CAI:MIPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Minapharm Pharmaceuticals (CAI:MIPH) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

El-Bardissi Street, 2T Takseem Asmaa Fahmy Street, Heliopolis, Cairo, EGY

Website

http://www.minapharm.com

Minapharm Pharmaceuticals produces prescription drugs in Egypt and the Middle East. It produces drugs for many segments such as biogenetics, orthopedic, ophthalmology, miscellaneous, dermatology, gastroenterology, cardiology, and uro-gynaecology lines.

Minapharm Pharmaceuticals (CAI:MIPH) Headlines

No Headlines